Video

Ester Oh, PhD: Sex Differences in Cardiovascular Disease Risk for Chronic Kidney Disease Patients

Author(s):

Females generally have a lower risk of cardiovascular disease compared to males.

While it is well-established that females have lower risks of cardiovascular disease, does that hold true for female patients with chronic kidney disease (CKD)?

In new research presented during the 2022 American Society of Nephrology (ASN) Annual Meeting in Orlando, a team led by Ester S. Oh, PhD, University of Colorado Anschutz Medical Campus, examined sex differences for cardiovascular disease risk for patients with chronic kidney disease.

“There are not many studies that examine the sex differences in cardiovascular risk in kidney disease and it has been known in the general population that females have a lower cardiovascular risk,” Oh said. “We don’t know if that translates to patients with chronic kidney disease.”

The results show females do have a lower cardiovascular disease in the non-chronic kidney disease cohort, but there was no sex differences in terms of cardiovascular disease risk among patients with chronic kidney disease.

There were no observed differences in a group in the odds ratio of a higher ASCVD score between males with chronic kidney disease aged 18-75 years and non-CKD males of the same age.

The results also show females aged 18-75 years with CKD had a higher odds of intermediate-high vs low-borderline ASCVD risk score compared to females aged at least 55 years without CKD.

Related Videos
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Braden Kuo, MD | Credit: Mass Gen
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Satish Rao, MD, PhD | Credit: ACG
Mazen Noureddin, MD, MHSc | Credit: Houston Methodist
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
© 2024 MJH Life Sciences

All rights reserved.